|Anteo Diagnostics Limited -- Australia Stock|| |
AUD 0.01 0.01 50%
Chief Scientific Officer
Dr. Nobuyoshi Joe Maeji, Ph.D., is Founder, Chief Scientific Officer of Anteo Diagnostics Limited. Dr. Joe Maeji is the founder of BioLayer. Prior to forming Bio Layer, Dr. Maeji held the position of Head of Research for Mimotopes Pty Ltd and Sr. Director for Small Molecule Drug Discovery for Chiron. At Mimotopes Pty Ltd., he directed RD, production as well as commercialization of products and technologies during the growth of this company
Executive Since 2009 Ph.D
61 7 3219 0085 http://www.anteodx.com
Maeji holds a Ph.D. in Polymer Engineering from the Tokyo Institute of Technology.
The company has return on total asset (ROA)
of (2.66) %
which means that it has lost $2.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (68.77) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 667.7 K in total debt with debt to equity ratio (D/E) of 11.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Anteo Diagnostics Limited has Current Ratio of 1.15 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.
Anteo Diagnostics Limited, a medical technology company, develops and commercializes specialized surfaces for use in life sciences industries in Australia. Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in Eight Mile Plains, QLD and employs 99 people.